Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease.

Liu B, Luo W, Mo Y, Wei C, Tao R, Han M.

Neurosci Lett. 2019 Jun 2;707:134313. doi: 10.1016/j.neulet.2019.134313. [Epub ahead of print]

PMID:
31167116
2.

Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder.

Fantini ML, Macedo L, Zibetti M, Sarchioto M, Vidal T, Pereira B, Marques A, Debilly B, Derost P, Ulla M, Vitello N, Cicolin A, Lopiano L, Durif F.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):174-9. doi: 10.1136/jnnp-2014-307904. Epub 2014 Jul 8.

3.

Impulse Control and Related Disorders in Parkinson's Disease.

Weintraub D, Claassen DO.

Int Rev Neurobiol. 2017;133:679-717. doi: 10.1016/bs.irn.2017.04.006. Epub 2017 Jun 1. Review.

PMID:
28802938
4.

Sleep and REM sleep behaviour disorder in Parkinson's disease with impulse control disorder.

Fantini ML, Figorilli M, Arnulf I, Zibetti M, Pereira B, Beudin P, Puligheddu M, Cormier-Dequaire F, Lacomblez L, Benchetrit E, Corvol JC, Cicolin A, Lopiano L, Marques A, Durif F.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):305-310. doi: 10.1136/jnnp-2017-316576. Epub 2017 Oct 24.

PMID:
29066517
5.

Long term follow-up of Parkinson's disease patients with impulse control disorders.

Sohtaoğlu M, Demiray DY, Kenangil G, Ozekmekçi S, Erginöz E.

Parkinsonism Relat Disord. 2010 Jun;16(5):334-7. doi: 10.1016/j.parkreldis.2010.02.006. Epub 2010 Mar 11.

PMID:
20223696
6.
7.

[Impulse control disorders in Parkinson's disease: A cohort of 35 patients].

Carrière N, Kreisler A, Dujardin K, Destée A, Defebvre L.

Rev Neurol (Paris). 2012 Feb;168(2):143-51. doi: 10.1016/j.neurol.2011.07.010. Epub 2011 Nov 29. French.

PMID:
22129474
8.

Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.

Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, Meucci N, Canesi M, Zecchinelli AL, Tesei S, Mariani CB, Sacilotto G, Zini M, Pezzoli G.

Mov Disord. 2015 Apr 15;30(5):696-704. doi: 10.1002/mds.26160. Epub 2015 Mar 11.

PMID:
25757654
9.

Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up.

Hanna JA, Scullen T, Kahn L, Mathkour M, Gouveia EE, Garces J, Evans LM, Lea G, Houghton DJ, Biro E, Bui CJ, Sulaiman OA, Smith RD.

J Neurosurg. 2018 Sep 1:1-6. doi: 10.3171/2018.4.JNS171909. [Epub ahead of print]

PMID:
30265192
10.

Long-term follow-up of impulse control disorders in Parkinson's disease.

Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D.

Mov Disord. 2008 Jan;23(1):75-80.

11.

Effectiveness and safety of acupuncture combined with Madopar for Parkinson's disease: a systematic review with meta-analysis.

Liu H, Chen L, Zhang Z, Geng G, Chen W, Dong H, Chen L, Zhan S, Li T.

Acupunct Med. 2017 Dec;35(6):404-412. doi: 10.1136/acupmed-2016-011342. Epub 2017 Nov 27. Review.

PMID:
29180347
12.

Impulse-Control Disorders in Parkinson's Disease: A Meta-Analysis and Review of Case-Control Studies.

Molde H, Moussavi Y, Kopperud ST, Erga AH, Hansen AL, Pallesen S.

Front Neurol. 2018 May 22;9:330. doi: 10.3389/fneur.2018.00330. eCollection 2018.

13.

A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson's disease.

Kim A, Kim YE, Kim HJ, Yun JY, Yang HJ, Lee WW, Shin CW, Park H, Jung YJ, Kim A, Ehm G, Kim Y, Jang M, Jeon B.

Parkinsonism Relat Disord. 2018 Nov;56:3-8. doi: 10.1016/j.parkreldis.2018.07.010. Epub 2018 Jul 20.

PMID:
30054182
14.

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's Disease.

Erga AH, Dalen I, Ushakova A, Chung J, Tzoulis C, Tysnes OB, Alves G, Pedersen KF, Maple-Grødem J.

Front Neurol. 2018 Feb 28;9:109. doi: 10.3389/fneur.2018.00109. eCollection 2018.

15.

Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.

Marques A, Figorilli M, Pereira B, Derost P, Debilly B, Beudin P, Vidal T, Durif F, Fantini ML.

Sleep Med. 2018 Aug;48:148-154. doi: 10.1016/j.sleep.2018.02.004. Epub 2018 Mar 1.

PMID:
29913341
16.

Motor subtypes and other risk factors associated with drooling in Parkinson's disease patients.

Mao CJ, Xiong YT, Wang F, Yang YP, Yuan W, Zhu C, Chen J, Liu CF.

Acta Neurol Scand. 2018 May;137(5):509-514. doi: 10.1111/ane.12893. Epub 2018 Jan 9.

PMID:
29315470
17.

Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Catalan MJ, Molina-Arjona JA, Mir P, Cubo E, Arbelo JM, Martinez-Martin P; EDIS Study Group.

J Neurol. 2018 Jun;265(6):1279-1287. doi: 10.1007/s00415-018-8803-1. Epub 2018 Mar 20.

PMID:
29557989
18.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
19.

Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.

Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A, Herranz Barcenas A, Vela L, Sanchez Alonso P, Mata M, Olmedilla Gonzalez N, Mahillo Fernandez I.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):840-4. doi: 10.1136/jnnp-2013-306787. Epub 2014 Jan 16.

PMID:
24434037
20.

A survey of impulse control disorders in Parkinson's disease patients in Shanghai area and literature review.

Wang XP, Wei M, Xiao Q.

Transl Neurodegener. 2016 Feb 17;5:4. doi: 10.1186/s40035-016-0051-7. eCollection 2016.

Supplemental Content

Support Center